HRP20210814T1 - Derivati piridokinazolina korisni kao inhibitori proteinskih kinaza - Google Patents
Derivati piridokinazolina korisni kao inhibitori proteinskih kinaza Download PDFInfo
- Publication number
- HRP20210814T1 HRP20210814T1 HRP20210814TT HRP20210814T HRP20210814T1 HR P20210814 T1 HRP20210814 T1 HR P20210814T1 HR P20210814T T HRP20210814T T HR P20210814TT HR P20210814 T HRP20210814 T HR P20210814T HR P20210814 T1 HRP20210814 T1 HR P20210814T1
- Authority
- HR
- Croatia
- Prior art keywords
- pyrido
- quinazoline
- carboxamide
- oxo
- unbranched
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F24—HEATING; RANGES; VENTILATING
- F24C—DOMESTIC STOVES OR RANGES ; DETAILS OF DOMESTIC STOVES OR RANGES, OF GENERAL APPLICATION
- F24C7/00—Stoves or ranges heated by electric energy
- F24C7/08—Arrangement or mounting of control or safety devices
- F24C7/082—Arrangement or mounting of control or safety devices on ranges, e.g. control panels, illumination
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F24—HEATING; RANGES; VENTILATING
- F24C—DOMESTIC STOVES OR RANGES ; DETAILS OF DOMESTIC STOVES OR RANGES, OF GENERAL APPLICATION
- F24C7/00—Stoves or ranges heated by electric energy
- F24C7/08—Arrangement or mounting of control or safety devices
- F24C7/087—Arrangement or mounting of control or safety devices of electric circuits regulating heat
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Mechanical Engineering (AREA)
- Combustion & Propulsion (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES201730759 | 2017-06-01 | ||
| PCT/ES2018/070396 WO2018220252A1 (es) | 2017-06-01 | 2018-05-31 | Derivados de piridoquinazolina eficaces como inhibidores de proteína quinasa |
| EP18759146.6A EP3632912B1 (en) | 2017-06-01 | 2018-05-31 | Pyridoquinazoline derivatives useful as protein kinase inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20210814T1 true HRP20210814T1 (hr) | 2021-06-25 |
Family
ID=61569288
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HRP20210814TT HRP20210814T1 (hr) | 2017-06-01 | 2018-05-31 | Derivati piridokinazolina korisni kao inhibitori proteinskih kinaza |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US11021479B2 (https=) |
| EP (1) | EP3632912B1 (https=) |
| JP (1) | JP7110335B2 (https=) |
| KR (1) | KR102629854B1 (https=) |
| CN (1) | CN111247143B (https=) |
| AU (1) | AU2018278283B2 (https=) |
| CA (1) | CA3066009A1 (https=) |
| CY (1) | CY1124087T1 (https=) |
| DK (1) | DK3632912T3 (https=) |
| EA (1) | EA037384B1 (https=) |
| ES (1) | ES2881960T3 (https=) |
| HR (1) | HRP20210814T1 (https=) |
| HU (1) | HUE054792T2 (https=) |
| LT (1) | LT3632912T (https=) |
| MX (1) | MX385475B (https=) |
| PL (1) | PL3632912T3 (https=) |
| PT (1) | PT3632912T (https=) |
| RS (1) | RS61833B1 (https=) |
| SI (1) | SI3632912T1 (https=) |
| SM (1) | SMT202100312T1 (https=) |
| WO (1) | WO2018220252A1 (https=) |
| ZA (1) | ZA201908372B (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7525609B2 (ja) | 2020-01-31 | 2024-07-30 | エルジー エナジー ソリューション リミテッド | 多層構造の無機物層を含む分離膜一体型電極の製造方法及びそれによる分離膜一体型電極 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4551460A (en) | 1982-05-10 | 1985-11-05 | Hoffmann-La Roche Inc. | Pyrido[2,1-b]quinazoline derivatives useful as agents for treatment of allergic conditions and vascular disorders involving thrombosis |
| DE69713139T2 (de) * | 1996-11-26 | 2002-12-19 | American Cyanamid Co., Madison | Hetero-biaryl-pyridochinazolinonderivate als antikrebsmittel |
| US20050192314A1 (en) * | 2003-11-13 | 2005-09-01 | Ambit Biosciences Corporation | Urea derivatives as C-kit modulators |
| CA2709784A1 (en) * | 2007-12-21 | 2009-07-09 | University Of Rochester | Method for altering the lifespan of eukaryotic organisms |
| WO2010061971A1 (ja) | 2008-11-28 | 2010-06-03 | 興和株式会社 | ピリジン－３－カルボキシアミド誘導体 |
| EP3119781B1 (en) * | 2014-03-20 | 2020-09-16 | The Johns Hopkins University | Compounds which inhibit rna polymerase, compositions including such compounds, and their use |
-
2018
- 2018-05-31 MX MX2019014436A patent/MX385475B/es unknown
- 2018-05-31 HR HRP20210814TT patent/HRP20210814T1/hr unknown
- 2018-05-31 AU AU2018278283A patent/AU2018278283B2/en active Active
- 2018-05-31 CN CN201880048531.4A patent/CN111247143B/zh active Active
- 2018-05-31 EP EP18759146.6A patent/EP3632912B1/en active Active
- 2018-05-31 HU HUE18759146A patent/HUE054792T2/hu unknown
- 2018-05-31 RS RS20210545A patent/RS61833B1/sr unknown
- 2018-05-31 US US16/615,867 patent/US11021479B2/en active Active
- 2018-05-31 JP JP2020516962A patent/JP7110335B2/ja active Active
- 2018-05-31 SI SI201830289T patent/SI3632912T1/sl unknown
- 2018-05-31 EA EA201992793A patent/EA037384B1/ru unknown
- 2018-05-31 CA CA3066009A patent/CA3066009A1/en active Pending
- 2018-05-31 LT LTEP18759146.6T patent/LT3632912T/lt unknown
- 2018-05-31 WO PCT/ES2018/070396 patent/WO2018220252A1/es not_active Ceased
- 2018-05-31 PT PT187591466T patent/PT3632912T/pt unknown
- 2018-05-31 DK DK18759146.6T patent/DK3632912T3/da active
- 2018-05-31 PL PL18759146T patent/PL3632912T3/pl unknown
- 2018-05-31 KR KR1020197038842A patent/KR102629854B1/ko active Active
- 2018-05-31 ES ES18759146T patent/ES2881960T3/es active Active
- 2018-05-31 SM SM20210312T patent/SMT202100312T1/it unknown
-
2019
- 2019-12-13 ZA ZA2019/08372A patent/ZA201908372B/en unknown
-
2021
- 2021-05-20 CY CY20211100437T patent/CY1124087T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2018278283A1 (en) | 2019-12-19 |
| JP7110335B2 (ja) | 2022-08-01 |
| BR112019024892A2 (pt) | 2020-06-16 |
| EP3632912A1 (en) | 2020-04-08 |
| EA037384B1 (ru) | 2021-03-23 |
| RS61833B1 (sr) | 2021-06-30 |
| CA3066009A1 (en) | 2018-12-06 |
| LT3632912T (lt) | 2021-06-10 |
| AU2018278283B2 (en) | 2021-06-17 |
| MX385475B (es) | 2025-03-18 |
| US20200148676A1 (en) | 2020-05-14 |
| JP2020521817A (ja) | 2020-07-27 |
| CN111247143A (zh) | 2020-06-05 |
| PL3632912T3 (pl) | 2021-09-06 |
| PT3632912T (pt) | 2021-06-02 |
| US11021479B2 (en) | 2021-06-01 |
| DK3632912T3 (da) | 2021-05-10 |
| SMT202100312T1 (it) | 2021-07-12 |
| KR102629854B1 (ko) | 2024-01-25 |
| HUE054792T2 (hu) | 2021-09-28 |
| CY1124087T1 (el) | 2022-05-27 |
| CN111247143B (zh) | 2022-07-05 |
| KR20200011990A (ko) | 2020-02-04 |
| SI3632912T1 (sl) | 2021-08-31 |
| ES2881960T3 (es) | 2021-11-30 |
| WO2018220252A1 (es) | 2018-12-06 |
| MX2019014436A (es) | 2020-02-10 |
| ZA201908372B (en) | 2021-04-28 |
| EP3632912B1 (en) | 2021-03-17 |
| EA201992793A1 (ru) | 2020-03-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2931085C (en) | Cyclic sulfone and sulfoximine analogs and uses thereof | |
| CA2903288C (en) | N-acyl-n'-(pyridin-2-yl) ureas and analogs exhibiting anti-cancer and anti-proliferative activities | |
| ES2630705T3 (es) | Compuestos de piridilo sustituidos con triazolilo útiles como inhibidores de cinasas | |
| ES2823477T3 (es) | Aril éteres y usos de los mismos | |
| AU2015313782B2 (en) | Compounds and compositions as RAF kinase inhibitors | |
| HRP20201985T1 (hr) | Piridonski spoj kao c-met inhibitor | |
| ME02672B (me) | Fenil-3-aza-bicikl0[3.1.0]heks-3-il-metanoni i njihova primena kao medikament | |
| JP2016534134A5 (https=) | ||
| RU2019104890A (ru) | Замещенные тиазолопиридиновые соединения в качестве ингибиторов malt1 | |
| ME02667B (me) | Spiro-prstenasti spoj koji sadrži dušik i njegova upotreba u medicini | |
| HRP20210869T1 (hr) | Pripravci spojeva i njihova upotreba | |
| CA2764728A1 (en) | Janus kinase inhibitor compounds and methods | |
| JP2006518341A (ja) | ヒストンデアセチラーゼ（ｈｄａｃ）阻害剤としてのヒドロキサム酸誘導体 | |
| JP2021500339A (ja) | タンパク質キナーゼ阻害剤としての複素環化合物 | |
| WO2019060611A1 (en) | CYCLIC IMINOPYRIMIDINE DERIVATIVES AS INHIBITORS OF KINASES | |
| ES2989149T3 (es) | Inhibidores de HAT p300/CBP | |
| JP2016513702A (ja) | Ｐ２ｘ７調節物質 | |
| JP2016501185A5 (https=) | ||
| JP2020525512A (ja) | 癌および他の疾患を処置するためのＡＴＦ４阻害剤としての２−（４−クロロフェノキシ）−Ｎ−（（１−（２−（４−クロロフェノキシ）エチンアゼチジン（ｅｔｈｙｎａｚｅｔｉｄｉｎ）−３−イル）メチル）アセトアミド誘導体および関連化合物 | |
| HRP20220472T1 (hr) | Novi derivati heteroarilamida kao selektivni inhibitori histonskih deacetilaza 1 i 2 (hdac1-2) | |
| HRP20180973T1 (hr) | Supstituirani tiazolski ili oksazolski antagonisti p2x7 receptora | |
| RU2016112963A (ru) | Новые производные триазолопиразина и их применение | |
| JP2015502371A5 (https=) | ||
| JP2019510801A5 (https=) | ||
| WO2024120471A1 (en) | Compounds targeting mutant of p53 |